Navigation Links
Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company

ROCHESTER, Minn., Feb. 5 /PRNewswire/ -- Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.

Clinical testing of new medical therapies is an arduous process, which is difficult to plan, costly and habitually delayed. The industry spends over $30 billion a year on clinical trials, yet nearly 90% of trials fail to meet their timelines or budgets. The result has been longer delivery times and great disappointment among patients researchers and clinical trial sponsors.

"Centerphase couples its proprietary methodologies and technologies with Mayo Clinic's medical and informatics expertise, to create a unique solution that we expect will greatly accelerate clinical trial performance," stated Gary Lubin, President and CEO of the new company. "Centerphase is the first independent clinical trials office and seeks to build on its relationship with Mayo Clinic by collaborating with select academic medical centers and healthcare networks."

As part of the new agreement, Mayo Clinic will access its Enterprise Data Trust (EDT) to provide Centerphase de-identified patient information to perform protocol review and optimization and help identify Mayo patients that potentially qualify for enrollment in a specific clinical trial.  Mayo Clinic's Enterprise Data Trust (EDT) is a secure collection of data on over 7 million patients from health records, education, research and administrative systems, organized to support information retrieval, business intelligence, and high-level decision-making.  Mayo's EDT is HIPAA (Health Insurance Portability and Accountability Act) compliant and has been reviewed by Mayo's Institutional Review Board (IRB) as well.

"Centerphase will benefit from the intensive work Mayo has invested over the years in the development of a state of the art patient record health information system. This system, the EDT, will be leveraged by Mayo informatics experts who will conduct a rapid database review of potential Mayo patients qualifying for enrolment into clinical trials," says Jean-Pierre Kocher Ph.D. Chair of the Division of Biomedical Statistics and Informatics.

Wayne Nicholson M.D., PharmD, Mayo Clinic who will oversee the collaboration, added, "Mayo's goal is to accelerate the introduction of novel treatment options for our patients by setting the industry standard for efficiency and quality in clinical trials. Our engagement with Centerphase will bring us closer to this goal."  Mayo Clinic holds an equity position in Centerphase.

About Centerphase Solutions, Inc.

Centerphase provides high quality, predictable, timely clinical services to the biopharmaceutical industry using proprietary technologies licensed through a collaboration with Mayo Clinic. Centerphase is founded by biopharmaceutical veterans Gary Lubin, Chief Executive Officer, and Jeff Tarlowe, Chief Operating Officer; they managed Merck & Co., Inc.'s venture unit before starting the new company. Per Lofberg, former CEO of Merck's venture group and recently appointed President of CVS Caremark's PBM business, will serve as the Chairman of Centerphase. Beth Harper, a leading expert in clinical trial site management, joins the team as Chief Clinical Officer.

For more information, please visit or contact:

Centerphase Solutions, Inc.

600 East Crescent Avenue Suite 205

Upper Saddle River, NJ 07458


Tel: 973-629-3777

About Mayo Clinic and Mayo Clinic's Office of Intellectual Property

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers, and 50,100 allied health staff work at Mayo Clinic, which has campuses in Rochester, Minn.; Jacksonville, Fla.; and Scottsdale/Phoenix, Ariz.; and community-based providers in more than 70 locations in southern Minnesota., western Wisconsin and northeast Iowa. These locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to For information about research and education, visit ( is available as a resource for your health stories.

Mayo Clinic's Office of Intellectual Property has a more than 20 years of experience in technology commercialization within academic medicine. The Office of Intellectual Property at Mayo Clinic serves as a bridge between discoveries and the marketplace. The Office works closely with Mayo physicians and scientists to evaluate and develop inventions, ideas and discoveries that have the potential to transform healthcare and generate income to support Mayo patient care, education and research. Mayo Clinic's Office of Intellectual Property has filed more than 2,400 patents resulting in over 600 active patent-licensing agreements with industry.

For more information, please visit

SOURCE Centerphase Solutions, Inc.



SOURCE Centerphase Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
2. Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO
3. Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market
4. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
5. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
6. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
7. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
8. BD Launches Be a Flu Fighter Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
9. Elekta Launches New Web Site for Global Health Care Community
10. Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada
11. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
Post Your Comments:
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel ... the company will present at the LD Micro Main Event. ... Sunset Boulevard Hotel in Los Angeles, CA. ... present on Thursday, December 3, at 9:00 am Pacific time ... at least 10 minutes prior to the start of the ...
(Date:12/1/2015)... Dec. 1, 2015   MabVax Therapeutics Holdings, Inc ... announces it has filed an Investigational New Drug Application ... for the Company,s lead fully human antibody product HuMab ... MabVax plans to initiate the Phase I clinical trial ... --> The planned Phase I trial will ...
(Date:12/1/2015)... 2015   Craneware, Inc ., the healthcare ... announced the company will showcase a new version ... solution at the American Society for Health-System ... The new features are focused on simplifying and ... managing enterprise-wide pharmacy charges to ensure compliance and ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... Speech and physical therapies are traditionally conducted ... and under the right circumstances, these practices can be merged. This combination ... his or her therapeutic sessions, as well as gives the physical and speech ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... Libertyville, IL (PRWEB) , ... December 01, 2015 ... ... catheters, keeping their independence is everything. That is why Hollister Incorporated has launched ... excited to offer this next product in the VaPro touch free catheter portfolio,” ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of ... latest addition to the devices for sale in the United States. Clarity is ... long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to own ...
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
Breaking Medicine News(10 mins):